GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSource Co Ltd (TSE:4880) » Definitions » Price-to-Free-Cash-Flow

CellSource Co (TSE:4880) Price-to-Free-Cash-Flow : N/A (As of Jun. 04, 2024)


View and export this data going back to 2019. Start your Free Trial

What is CellSource Co Price-to-Free-Cash-Flow?

As of today (2024-06-04), CellSource Co's share price is 円1306.00. CellSource Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jan. 2024 was 円0.00. Hence, CellSource Co's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for CellSource Co's Price-to-Free-Cash-Flow or its related term are showing as below:

TSE:4880' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0   Med: 0   Max: 506.07
Current: 51.57

During the past 7 years, CellSource Co's highest Price-to-Free-Cash-Flow Ratio was 506.07. The lowest was 0.00. And the median was 0.00.

TSE:4880's Price-to-Free-Cash-Flow is ranked worse than
65.26% of 213 companies
in the Biotechnology industry
Industry Median: 31.04 vs TSE:4880: 51.57

CellSource Co's Free Cash Flow per Share for the three months ended in Jan. 2024 was 円0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was 円0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 17.60% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 24.30% per year.

During the past 7 years, CellSource Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 53.10% per year. The lowest was 17.60% per year. And the median was 41.05% per year.


CellSource Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for CellSource Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSource Co Price-to-Free-Cash-Flow Chart

CellSource Co Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial 83.24 182.15 147.85 112.82 70.42

CellSource Co Quarterly Data
Oct18 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 70.42 -

Competitive Comparison of CellSource Co's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, CellSource Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellSource Co's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellSource Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where CellSource Co's Price-to-Free-Cash-Flow falls into.



CellSource Co Price-to-Free-Cash-Flow Calculation

CellSource Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=1306.00/0
=N/A

CellSource Co's Share Price of today is 円1306.00.
CellSource Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

CellSource Co  (TSE:4880) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


CellSource Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of CellSource Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


CellSource Co (TSE:4880) Business Description

Traded in Other Exchanges
N/A
Address
Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.

CellSource Co (TSE:4880) Headlines

No Headlines